Oak Street Health Reports Second Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Oak Street Health (OSH) PT Lowered to $70 at Cantor Fitzgerald
August 10, 2021 3:49 PM EDTCantor Fitzgerald analyst Steven Halper lowered the price target on Oak Street Health (NYSE: OSH) to $70.00 (from $75.00) while maintaining an Overweight rating.
The analyst commented, "We reiterate our Overweight rating on OSH shares, but lower our price target to $70 from $75. After the market close... More
Oak Street Health (OSH) Misses Q2 EPS by 10c
August 9, 2021 4:28 PM EDTOak Street Health (NYSE: OSH) reported Q2 EPS of ($0.44), $0.10 worse than the analyst estimate of ($0.34). Revenue for the quarter came in at $353.1 million versus the consensus estimate of $318 million.
GUIDANCE:
Oak Street Health sees FY2021 revenue of $1.37-1.4 billion, versus the... More
